Drugs / Deciatbine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01758367 | Dec 2012 → Jun 2017 | acute myeloid leukemia | Chinese PLA General Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Deciatbine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01758367 ↗ |
| Action | Activate | “decitabine induce FOXP3 expression in CD4+ T cells” NCT01758367 ↗ |